MAPS Releases New Version of Psychedelic Emergency Video
MAPS has just released of the newest version of MAPS psychedelic emergency video. The newest version is available on Youtube and is a concise educational drama about how to help someone who is having a difficult psychedelic experience.
MAPS mission is to develop MDMA, LSD, Psilocybin, and Marijuana into legal prescription medicines for therapeutic applications. We are actively developing and funding clinical trials with human subjects in accordance to the guidelines set by the United States Food and Drug Administration and the European Medicines Agency. During this process we are training therapists to administer psychedelic drugs in therapeutic settings. We will open psychedelic therapy clinics around the world when these substances are approved as prescription medicines. We are also engaged in efforts to educate people about the benefits and risks of these substances and other psychedelics.
MAPS is a membership-based nonprofit organization that counts on donations from people like you to conduct achieve our mission. Please become a today at http://maps.org/donate
http://www.youtube.com/watch?v=1aBjoARwlOY
According to US Government Statistics, approximately 600,000 new users try LSD each year in the US alone. Similar numbers are surely found in other nations. Many of these new users are unprepared and uninformed about how to handle difficult psychedelic experiences. Please help MAPS spread this video far and wide by sharing it with your family, friends and colleagues. MAPS would like everyone to be prepared to help someone having a psychedelic induced crisis by knowing four basic principals of psychedelic emergency services:
- Create a safe space.
- Sitting, not guiding.
- Talk through, not down.
- Difficult is not necessarily bad
MAPS mission is to develop MDMA, LSD, Psilocybin, and Marijuana into legal prescription medicines for therapeutic applications. We are actively developing and funding clinical trials with human subjects in accordance to the guidelines set by the United States Food and Drug Administration and the European Medicines Agency. During this process we are training therapists to administer psychedelic drugs in therapeutic settings. We will open psychedelic therapy clinics around the world when these substances are approved as prescription medicines. We are also engaged in efforts to educate people about the benefits and risks of these substances and other psychedelics.
MAPS is a membership-based nonprofit organization that counts on donations from people like you to conduct achieve our mission. Please become a today at http://maps.org/donate
Publicité